The in vitro data showing acetylcholine inhibition of VTN synthesis and release by hepatocytes through M1 muscarinic receptors was confirmed in vivo by showing that the M1/3 agonist, bethanechol, reduced plasma VTN levels after the MCAO stroke. The gene discussed is VTN; the disease is stroke disorder.